Ajay Keshava is Senior Vice President of Commercialization Strategy at Magnolia Market Access. Ajay has over 20 years of experience both in industry and management consulting, in which he has covered all aspects of cross-functional development, approval and launch of drug, device and combination products, business development and acquisitions, interactions with regulators, as well as organizational design and scale up for both pharma and device companies.

Prior to joining Magnolia, Ajay worked at United Therapeutics, a manufacturer of specialty drugs for orphan lung diseases. During his tenure, he built the corporation’s program management function that assisted with key commercial acquisitions, and structured, facilitated, and oversaw the development and commercialization of oral, inhaled, and parenteral therapies. Ajay held a significant leadership position in the development, approval, and launch of the first dry powder inhaled treatment for pulmonary arterial hypertension. He also led the development and release of the company’s first digital therapy agnostic app focused on pulmonary hypertension and built the initial strategy for United Therapeutics’ connected device program.

Before working in industry, Ajay spent a number of years in pharmaceutical consulting, initially in operational excellence, with projects that focused on decreasing cycle time, improving throughput, and gaining efficiencies. His focus later shifted to process and organizational design in pharmacovigilance, regulatory, quality and compliance organizations for both small, mid-sized, and large pharma and biotech organizations.

Ajay received his Bachelor of Chemical Engineering and Master of Biomedical Engineering from the University of New South Wales in Sydney, Australia, and a Master of Public Affairs from Columbia University in New York.